Flupentixol Decanoate Injection Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Flupentixol Decanoate Injection is a long-acting depot antipsychotic medicine utilized for schizophrenia management, chronic psychotic disorder treatment, and maintenance psychiatric therapy requiring sustained neuropsychiatric support.

The formulation contains Flupentixol Decanoate, a depot neuroleptic agent designed for prolonged antipsychotic activity through slow intramuscular release, helping maintain symptom control and treatment continuity in long-term psychiatric management programs.

Genliva Wellness LLP develops these formulations as a Flupentixol Decanoate Injection Manufacturer in India, while also operating as a Long Acting Antipsychotic Injection Exporter and Psychiatric Care Injectable Supplier for institutional healthcare providers and global CNS pharmaceutical markets.

Flupentixol Decanoate Injection is formulated for long-acting psychiatric therapy.

Depot antipsychotic injectable formulation
Frequently utilized in schizophrenia management
Supports prolonged psychiatric symptom control
Helps maintain treatment continuity support
Manufactured under stringent sterile standards
Intended for long-term neuropsychiatric care

This formulation is prescribed in psychiatric management therapies.

Treatment of schizophrenia conditions
Management of chronic psychotic disorders
Administered in maintenance psychiatric therapies
Utilized in long-term neuropsychiatric care
Helps support behavioral stabilization management
Frequently selected in depot antipsychotic treatment plans

Flupentixol Decanoate Injection delivers prolonged antipsychotic support for psychiatric management.

Valuable in long-term schizophrenia treatment
Frequently preferred in maintenance psychiatric care
Effective depot neuroleptic therapy support
Useful in chronic psychotic disorder management
Reliable long-acting injectable administration
Maintains dependable psychiatric therapeutic performance